News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
688,001 Results
Type
Article (39146)
Company Profile (283)
Press Release (648572)
Section
Business (203940)
Career Advice (1996)
Deals (35386)
Drug Delivery (89)
Drug Development (80849)
Employer Resources (168)
FDA (16100)
Job Trends (14809)
News (344702)
Policy (32453)
Tag
Academia (2530)
Alliances (49206)
Alzheimer's disease (1257)
Approvals (16051)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1365)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64695)
Collaboration (482)
Compensation (260)
COVID-19 (2541)
C-suite (108)
Data (1389)
Diabetes (172)
Diagnostics (6172)
Earnings (84894)
Employer resources (146)
Events (110012)
Executive appointments (394)
FDA (16769)
Funding (426)
Gene therapy (195)
GLP-1 (597)
Government (4333)
Healthcare (18694)
Infectious disease (2633)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16339)
Job creations (3626)
Job search strategy (1418)
Layoffs (418)
Legal (7862)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13216)
Medtech (13221)
Mergers & acquisitions (19207)
Metabolic disorders (452)
Neuroscience (1577)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1693)
Obesity (258)
Opinion (183)
Patents (117)
People (56467)
Phase I (20120)
Phase II (28494)
Phase III (21237)
Pipeline (514)
Postmarket research (2561)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5892)
Regulatory (21666)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3563)
United States (15141)
Vaccines (563)
Weight loss (181)
Date
Last 7 days (580)
Last 30 days (2251)
Last 365 days (35164)
2024 (35005)
2023 (40078)
2022 (51178)
2021 (55715)
2020 (54094)
2019 (46544)
2018 (35022)
2017 (32115)
2016 (31486)
2015 (37557)
2014 (31326)
2013 (26355)
2012 (28575)
2011 (29268)
2010 (27332)
Location
Africa (713)
Arizona (195)
Asia (37277)
Australia (6087)
California (3809)
Canada (1449)
China (304)
Colorado (171)
Connecticut (176)
Europe (79898)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2959)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1080)
North Carolina (742)
Northern California (1693)
Ohio (146)
Pennsylvania (923)
South America (1092)
Southern California (1460)
Texas (547)
Utah (108)
Washington State (399)
688,001 Results for "srl inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
Hoth Therapeutics, Inc., a patient focused biopharmaceutical company, announced the entry into a joint development agreement with Wise Systems International SRL to leverage artificial intelligence utilizing the BioNeMo AI platform of Nvidia.
June 10, 2024
·
2 min read
Pharm Country
Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
Vela Diagnostics announced a research collaboration with SRL Inc, a premier Japanese healthcare service company.
October 2, 2023
·
2 min read
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Business
ReiThera Srl, The Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation
ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd vector and HIV T cell epitopes identified by the Ragon Institute, funded by the Bill & Melinda Gates Foundation.
January 22, 2024
·
6 min read
Policy
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USAThe Company expands its range of CGMP services to include small-scale commercial APIs
Dipharma Francis S.r.l. proudly announced that Dipharma Inc., its US facility located in Kalamazoo, MI, has been inspected by the U.S. Food and Drug Administration and has received the Establishment Inspection Report, satisfactorily closing the inspection process.
May 7, 2024
·
3 min read
EMMA International Consulting Group, Inc. and Thema srl Announce Strategic Partnership
This Strategic Partnership will enable EMMA International and Thema to Increase Their Geographical Offerings for the Medical Device Industry
January 20, 2023
·
2 min read
Business
Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy
Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostics, today announced that it has entered into a distribution agreement with Gepa Srl (“Gepa”), a distributor and supplier of diagnostic products in Italy.
November 29, 2022
·
4 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Business
Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck
Nerviano Medical Sciences S.r.l. announced today the signing of a collaboration agreement with licensing option with Merck Healthcare KGaA (Merck), for the next-generation highly selective and brain penetrant PARP1 inhibitor NMS-293.
September 21, 2022
·
5 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
1 of 68,801
Next
